Molecular basis for oncogenic signaling via Wnt-receptor pseudokinases

Bidragets beskrivning

Ovarian cancer (OC) is one of the most common gynecologic cancers that also has high mortality rate. This is due to resistant and metastatic forms of the disease that causes relapsing. Hence, there is an urgent need for new effective treatments for OC. Interestingly, it has been found that OC cells, among other types of cancer cells, have high expression of receptors that bind Wnt ligands, such as tyrosine kinase-like orphan receptor 1 and 2 (ROR1 and 2) and protein tyrosine kinase 7 (PTK7), which are not expressed at high levels in healthy adult tissues. My projects will give insight of how these Wnt-signaling receptors drive cancer progression and how by targeting their expression we could stop cancer growth. We use OC cell lines and patient-derived cells to study the oncogenic events driven by these receptors, including genes and signaling cascades they alter. In parallel, we will develop molecules that bind explicitly to these tumor-specific receptors and block their function.
Visa mer

Startår

2022

Slutår

2026

Beviljade finansiering

Juuli Raivola Orcid -palvelun logo
278 066 €

Finansiär

Finlands Akademi

Typ av finansiering

Forskardoktorer

Utlysning

Beslutfattare

Forskningsrådet för biovetenskap, hälsa och miljö
28.04.2022

Övriga uppgifter

Finansieringsbeslutets nummer

349787

Vetenskapsområden

Biokemi, cell- och molekylärbiologi

Forskningsområden

Biokemia, biofysiikka

Identifierade teman

cancer